Showing results (11-20 of 189) with videos related to
Sort By:
Pageof 19
Best Practice & Research. Clinical Rheumatology|July 14, 2009
Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapiesElsa Sousa, David IsenbergRheumatology (Oxford, England)|May 4, 2013
Effect of gender on clinical presentation in systemic lupus erythematosusGrainne Murphy, David IsenbergExpert Opinion on Biological Therapy|October 21, 2020
Anti-IFNαR Mabs for the treatment of systemic lupus erythematosusBethan Goulden, David IsenbergPresse Medicale (Paris, France : 1983)|May 6, 2014
Why and how should we measure disease activity and damage in lupus?Joy Feld, David IsenbergCurrent Opinion in Pharmacology|July 15, 2004
Anti B cell therapy (rituximab) in the treatment of autoimmune diseasesHanadi Kazkaz, David IsenbergClinical Medicine (London, England)|July 11, 2006
Working together to improve rheumatology servicesMatthew Adler, David IsenbergRheumatology (Oxford, England)|August 24, 2016
Kidney disease in primary anti-phospholipid antibody syndromeBorja Gracia-Tello, David IsenbergExpert Opinion on Pharmacotherapy|September 13, 2018
An evaluation of voclosporin for the treatment of lupus nephritisFang En Sin, David IsenbergFrontiers in Medicine|June 2, 2022
Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma VariationsSergio Gilaberte Reyzabal, David IsenbergLupus|January 21, 2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United KingdomAna Lorenzo-Vizcaya, David IsenbergPageof 19